Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis. Kornek B, Aboul-Enein F, Rostasy K, Milos R-I, Steiner I, Penzien J, Hellwig K, Pitarokoili K, Van's Gravesande K S, Karenfort M, et al. JAMA Neurol. 2013 Feb 18:1-7. PMID: 23420110. Abstract CommentRecommendBookmarkWatch